Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | geminin | 0.0205 | 0.1093 | 0.1093 |
Leishmania major | aldehyde dehydrogenase, mitochondrial precursor | 0.0068 | 0.0292 | 0.0292 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0068 | 0.0292 | 0.0292 |
Giardia lamblia | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0.0807 | 0.4634 | 1 |
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.0068 | 0.0292 | 0.0292 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.0019 | 0 | 0.5 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0068 | 0.0292 | 0.0292 |
Leishmania major | 3-hydroxy-3-methylglutaryl-CoA reductase | 0.1721 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0708 | 0.4053 | 0.4053 |
Brugia malayi | CHE-14 protein | 0.0708 | 0.4053 | 0.4053 |
Echinococcus granulosus | sterol regulatory element binding protein | 0.0708 | 0.4053 | 0.4053 |
Echinococcus granulosus | Protein patched homolog 1 | 0.0708 | 0.4053 | 0.4053 |
Trypanosoma cruzi | 3-hydroxy-3-methylglutaryl-CoA reductase | 0.1721 | 1 | 1 |
Toxoplasma gondii | aldehyde dehydrogenase | 0.0068 | 0.0292 | 1 |
Schistosoma mansoni | hydroxymethylglutaryl-CoA reductase (NADPH) | 0.1721 | 1 | 1 |
Trypanosoma cruzi | 3-hydroxy-3-methylglutaryl-CoA reductase, putative | 0.1721 | 1 | 1 |
Mycobacterium tuberculosis | Probable aldehyde dehydrogenase | 0.0068 | 0.0292 | 1 |
Loa Loa (eye worm) | abnormal chemotaxis protein 14 | 0.0708 | 0.4053 | 0.4053 |
Entamoeba histolytica | exodeoxyribonuclease III, putative | 0.0019 | 0 | 0.5 |
Schistosoma mansoni | niemann-pick C1 (NPC1) | 0.0708 | 0.4053 | 0.4053 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0068 | 0.0292 | 0.0292 |
Echinococcus multilocularis | protein dispatched 1 | 0.0708 | 0.4053 | 0.4053 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0068 | 0.0292 | 0.0292 |
Trichomonas vaginalis | 3-hydroxy-3-methylglutaryl-coenzyme A reductase, putative | 0.0807 | 0.4634 | 1 |
Echinococcus granulosus | hydroxymethylglutaryl coenzyme A reductase | 0.1721 | 1 | 1 |
Echinococcus multilocularis | sterol regulatory element binding protein | 0.0708 | 0.4053 | 0.4053 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0068 | 0.0292 | 0.0292 |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.0019 | 0 | 0.5 |
Echinococcus multilocularis | hydroxymethylglutaryl coenzyme A reductase | 0.1721 | 1 | 1 |
Trichomonas vaginalis | 3-hydroxy-3-methylglutaryl-coenzyme A reductase, putative | 0.0807 | 0.4634 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.1721 | 1 | 1 |
Echinococcus granulosus | Niemann Pick C1 protein | 0.0708 | 0.4053 | 0.4053 |
Plasmodium vivax | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0019 | 0 | 0.5 |
Schistosoma mansoni | patched 1 | 0.0708 | 0.4053 | 0.4053 |
Echinococcus multilocularis | geminin | 0.0205 | 0.1093 | 0.1093 |
Trichomonas vaginalis | 3-hydroxy-3-methylglutaryl-coenzyme A reductase, putative | 0.0807 | 0.4634 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.1093 | 0.1093 |
Plasmodium falciparum | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0019 | 0 | 0.5 |
Trypanosoma brucei | 3-hydroxy-3-methylglutaryl-CoA reductase, putative | 0.1721 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0708 | 0.4053 | 0.8747 |
Echinococcus multilocularis | Niemann Pick C1 protein | 0.0708 | 0.4053 | 0.4053 |
Echinococcus granulosus | aldehyde dehydrogenase mitochondrial | 0.0068 | 0.0292 | 0.0292 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.1093 | 0.1093 |
Mycobacterium ulcerans | hydroxymethylglutaryl-coenzyme a (HMG-CoA) reductase | 0.1721 | 1 | 1 |
Echinococcus multilocularis | protein patched | 0.0708 | 0.4053 | 0.4053 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 11 nM | Inhibitory activity against human thromboxane synthetase | ChEMBL. | 7199088 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.